Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation

Taraka Sai Pavan Grandhi, Thrimoorthy Potta, Rajeshwar Nitiyanandan, Indrani Deshpande, Kaushal Rege

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Tumors undergo periods of dormancy followed by reactivation leading to metastatic disease. Arrest in the G0/G1 phase of the cell cycle and resistance to chemotherapeutic drugs are key hallmarks of dormant tumor cells. Here, we describe a 3D platform of bladder cancer cell dormancy and reactivation facilitated by a novel aminoglycoside-derived hydrogel, Amikagel. These 3D dormant tumor microenvironments (3D-DTMs) were arrested in the G0/G1 phase and were highly resistant to anti-proliferative drugs. Inhibition of targets in the cellular protein production machinery led to induction of endoplasmic reticulum (ER) stress and complete ablation of 3D-DTMs. Nanoparticle-mediated calcium delivery significantly accelerated ER stress-mediated 3D-DTM death. Transfer of 3D-DTMs onto weaker and adhesive Amikagels resulted in selective reactivation of a sub-population of N-cadherin deficient cells from dormancy. Whole-transcriptome analyses further indicated key biochemical differences between dormant and proliferative cancer cells. Taken together, our results indicate that 3D bladder cancer microenvironments of dormancy and reactivation can facilitate fundamental advances and novel drug discovery in cancer.

Original languageEnglish (US)
Pages (from-to)171-185
Number of pages15
JournalBiomaterials
Volume142
DOIs
StatePublished - Oct 1 2017

Fingerprint

Tumor Microenvironment
Urinary Bladder Neoplasms
Tumors
Cell Cycle Resting Phase
Endoplasmic Reticulum Stress
Cells
G1 Phase
Neoplasms
Hydrogel
Aminoglycosides
Gene Expression Profiling
Cadherins
Drug Discovery
Pharmaceutical Preparations
Adhesives
Nanoparticles
Cell Cycle
Ablation
Hydrogels
Machinery

Keywords

  • 3D Tissue models
  • Cancer dormancy
  • Drug discovery
  • Reactivation

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation. / Pavan Grandhi, Taraka Sai; Potta, Thrimoorthy; Nitiyanandan, Rajeshwar; Deshpande, Indrani; Rege, Kaushal.

In: Biomaterials, Vol. 142, 01.10.2017, p. 171-185.

Research output: Contribution to journalArticle

Pavan Grandhi, Taraka Sai ; Potta, Thrimoorthy ; Nitiyanandan, Rajeshwar ; Deshpande, Indrani ; Rege, Kaushal. / Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation. In: Biomaterials. 2017 ; Vol. 142. pp. 171-185.
@article{5fe55af1fb664cf795c799f8e5cec354,
title = "Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation",
abstract = "Tumors undergo periods of dormancy followed by reactivation leading to metastatic disease. Arrest in the G0/G1 phase of the cell cycle and resistance to chemotherapeutic drugs are key hallmarks of dormant tumor cells. Here, we describe a 3D platform of bladder cancer cell dormancy and reactivation facilitated by a novel aminoglycoside-derived hydrogel, Amikagel. These 3D dormant tumor microenvironments (3D-DTMs) were arrested in the G0/G1 phase and were highly resistant to anti-proliferative drugs. Inhibition of targets in the cellular protein production machinery led to induction of endoplasmic reticulum (ER) stress and complete ablation of 3D-DTMs. Nanoparticle-mediated calcium delivery significantly accelerated ER stress-mediated 3D-DTM death. Transfer of 3D-DTMs onto weaker and adhesive Amikagels resulted in selective reactivation of a sub-population of N-cadherin deficient cells from dormancy. Whole-transcriptome analyses further indicated key biochemical differences between dormant and proliferative cancer cells. Taken together, our results indicate that 3D bladder cancer microenvironments of dormancy and reactivation can facilitate fundamental advances and novel drug discovery in cancer.",
keywords = "3D Tissue models, Cancer dormancy, Drug discovery, Reactivation",
author = "{Pavan Grandhi}, {Taraka Sai} and Thrimoorthy Potta and Rajeshwar Nitiyanandan and Indrani Deshpande and Kaushal Rege",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.biomaterials.2017.07.008",
language = "English (US)",
volume = "142",
pages = "171--185",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation

AU - Pavan Grandhi, Taraka Sai

AU - Potta, Thrimoorthy

AU - Nitiyanandan, Rajeshwar

AU - Deshpande, Indrani

AU - Rege, Kaushal

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Tumors undergo periods of dormancy followed by reactivation leading to metastatic disease. Arrest in the G0/G1 phase of the cell cycle and resistance to chemotherapeutic drugs are key hallmarks of dormant tumor cells. Here, we describe a 3D platform of bladder cancer cell dormancy and reactivation facilitated by a novel aminoglycoside-derived hydrogel, Amikagel. These 3D dormant tumor microenvironments (3D-DTMs) were arrested in the G0/G1 phase and were highly resistant to anti-proliferative drugs. Inhibition of targets in the cellular protein production machinery led to induction of endoplasmic reticulum (ER) stress and complete ablation of 3D-DTMs. Nanoparticle-mediated calcium delivery significantly accelerated ER stress-mediated 3D-DTM death. Transfer of 3D-DTMs onto weaker and adhesive Amikagels resulted in selective reactivation of a sub-population of N-cadherin deficient cells from dormancy. Whole-transcriptome analyses further indicated key biochemical differences between dormant and proliferative cancer cells. Taken together, our results indicate that 3D bladder cancer microenvironments of dormancy and reactivation can facilitate fundamental advances and novel drug discovery in cancer.

AB - Tumors undergo periods of dormancy followed by reactivation leading to metastatic disease. Arrest in the G0/G1 phase of the cell cycle and resistance to chemotherapeutic drugs are key hallmarks of dormant tumor cells. Here, we describe a 3D platform of bladder cancer cell dormancy and reactivation facilitated by a novel aminoglycoside-derived hydrogel, Amikagel. These 3D dormant tumor microenvironments (3D-DTMs) were arrested in the G0/G1 phase and were highly resistant to anti-proliferative drugs. Inhibition of targets in the cellular protein production machinery led to induction of endoplasmic reticulum (ER) stress and complete ablation of 3D-DTMs. Nanoparticle-mediated calcium delivery significantly accelerated ER stress-mediated 3D-DTM death. Transfer of 3D-DTMs onto weaker and adhesive Amikagels resulted in selective reactivation of a sub-population of N-cadherin deficient cells from dormancy. Whole-transcriptome analyses further indicated key biochemical differences between dormant and proliferative cancer cells. Taken together, our results indicate that 3D bladder cancer microenvironments of dormancy and reactivation can facilitate fundamental advances and novel drug discovery in cancer.

KW - 3D Tissue models

KW - Cancer dormancy

KW - Drug discovery

KW - Reactivation

UR - http://www.scopus.com/inward/record.url?scp=85026263663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026263663&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2017.07.008

DO - 10.1016/j.biomaterials.2017.07.008

M3 - Article

C2 - 28756304

AN - SCOPUS:85026263663

VL - 142

SP - 171

EP - 185

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -